Author

K. Papakostas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:genetic perturbation / CRISPR· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

E. Girardi· 2 shared G. Superti-Furga· 2 shared J. Konecka· 2 shared A. Cesar-Razquin· 1 shared A. Ingles-Prieto· 1 shared A. Ringler· 1 shared B. Guertl· 1 shared C.-H. Lardeau· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

E. Girardi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivApr 3, 2022

Gain-of-function genetic screens in human cells identify SLC transporters overcoming environmental nutrient restrictions

M. Rebsamen, E. Girardi, V. Sedlyarov…·G. Superti-Furga

This study uses gain-of-function genetic screens in human cells to identify SLC transporters that overcome nutrient limitations by enhancing uptake of essential amino acids.

DOI 10.26508/lsa.202201404

humanbulk RNA-seq

𝕏 PostBluesky

Cell BiologybioRxivAug 8, 2019

A widespread role for SLC transmembrane transporters in resistance to cytotoxic drugs

E. Girardi, A. Cesar-Razquin, K. Papakostas…·G. Superti-Furga

This study identifies SLC transporters critical for drug resistance using CRISPR screens in human cells, revealing widespread roles of SLCs in drug uptake and activity.

DOI 10.1038/s41589-020-0483-3

humangenetic perturbation / CRISPR

𝕏 PostBluesky